Compendium of Cancer Genome Aberrations

HAEM5:Volunteer Assignments and Opportunities: Difference between revisions

[unchecked revision][unchecked revision]
← Older editNewer edit →
VisualWikitext
No edit summary
No edit summary
Line 1,173: Line 1,173:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma, Not Otherwise Specified
|
|Holli Drendel
|
|PENDING
|
|
|
|
Line 1,189: Line 1,189:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma with Hyperdiploidy
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
|
|PENDING
|
|
|
|
Line 1,205: Line 1,205:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma with Hypodiploidy
|Ashwini Yenamandra PhD FACMG  Lisa Smith PhD FACMG  Yassmine Akkari PhD FACMG
|Ashwini Yenamandra PhD FACMG  Lisa Smith PhD FACMG  Yassmine Akkari PhD FACMG
|
|Complete
|
|
|
|
Line 1,213: Line 1,213:
|B-lymphoblastic leukaemia/lymphoma with iAMP21
|B-lymphoblastic leukaemia/lymphoma with iAMP21
|Disease
|Disease
|
|Holli authoring - Complete? Looks like needs more editing of tables
|
|
|
|
Line 1,221: Line 1,221:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma with iAMP21 [but was completed as a 5th edition page by Holli]
|Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte
|Holli M. Drendel, PhD, FACMGG, Carolinas Pathology Group, Charlotte
|
|?Complete
|
|
|
|
Line 1,237: Line 1,237:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma with t(9;22)(q34.1;q11.2); BCR-ABL1
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
|Afia Hasnain, MBBS, PhD; Yassmine Akkari, PhD, FACMG
|
|PENDING
|
|
|
|
Line 1,253: Line 1,253:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma, BCR-ABL1-Like
|Mark G. Evans, MD, University of California, Irvine  Fabiola Quintero-Rivera, MD, University of California, Irvine
|Mark G. Evans, MD, University of California, Irvine  Fabiola Quintero-Rivera, MD, University of California, Irvine
|
|Complete
|
|
|
|
Line 1,269: Line 1,269:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma with t(v;11q23.3); KMT2A-Rearranged
|Yassmine Akkari  Nicolas Millan
|Yassmine Akkari  Nicolas Millan
|
|PENDING
|
|
|
|
Line 1,285: Line 1,285:
|
|
|
|
|
|B lymphoblastic leukaemia/lymphoma with ETV6::RUNX1 fusion
|Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG  Cancer Category/Type    B-Lymphoblastic Leukemia/Lymphoma
|Marilena Melas, PhD; Yassmine Akkari, PhD, FACMG  Cancer Category/Type    B-Lymphoblastic Leukemia/Lymphoma
|
|PENDING
|
|
|
|
Line 1,301: Line 1,301:
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
|B lymphoblastic leukaemia/lymphoma with TCF3::PBX1 fusion
Line 1,317: Line 1,317:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma with t(1;19)(q23;p13.3); TCF3-PBX1
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
|
|PENDING
|
|
|
|
Line 1,333: Line 1,333:
|
|
|
|
|
|B-Lymphoblastic Leukemia/Lymphoma with t(5;14)(q31.1;q32.1); IGH/IL3
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
|Binu Porath, PhD. Vanderbilt University Medical Center, Nashville, TN  Linda D. Cooley, MD, MBA. Children's Mercy Kansas City, Kansas City, MO
|
|PENDING
|
|
|
|
Line 1,349: Line 1,349:
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations
|B-lymphoblastic leukaemia/lymphoma with other defined genetic alterations
Line 1,365: Line 1,365:
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|B-lymphoblastic leukaemia/lymphoma, NOS
|B-lymphoblastic leukaemia/lymphoma, NOS
Line 1,381: Line 1,381:
|
|
|
|
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|
|NEW (No Prior)
|-
|-
|RESOLVE 4th edition ALL-Related NON-WHO entities content
|RESOLVE 4th edition ALL-Related NON-WHO entities content
Retrieved from "https://test.ccga.io/index.php/HAEM5:Volunteer_Assignments_and_Opportunities"